Form 4: Tyra Biosciences Director Nina S. Kjellson Sells Shares

Director Nina S. Kjellson reports selling 4,825 shares of Tyra Biosciences (TYRA) at an average price of $16.2624 on January 23, 2025.

Summary

• On January 23, 2025, Nina S. Kjellson, a director of Tyra Biosciences, Inc. (TYRA), sold 4,825 shares of common stock.
• The shares were sold at a weighted average price of $16.2624, with individual transaction prices ranging from $16.25 to $16.39.
• Following the transaction, Kjellson indirectly owns 3,702,595 shares through Canaan XI L.P. and 447,396 shares through 2020+ Co-Investment L.P. Series 7.
• The filing indicates that the transaction was not made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Sentiment

Score: 5

Explanation: The document is a neutral regulatory filing. It doesn't inherently indicate positive or negative sentiment, but rather reports a transaction.

Industry Context

Form 4 filings are a routine part of the regulatory landscape for publicly traded companies, providing transparency into the transactions of company insiders. These filings are closely watched by investors seeking to understand the sentiment and actions of those with intimate knowledge of the company.

Stakeholder Impact

• The sale of shares by a director could be perceived negatively by some shareholders, potentially leading to a slight decrease in stock price, although the impact is likely to be minimal given the relatively small number of shares sold.

Key Dates